CLL Global Research Foundation

 

Upcoming Events
  • Home
  • CLL Information
    • Biology
    • Age & Symptoms
    • Diagnosis
    • Immunology
    • Prognostic Factors
    • Treatments
    • Familial CLL
    • Other
  • News & Views
    • Latest News
    • Upcoming Events
    • President’s Corner
    • Newsletters
    • Multimedia
  • Funded Research
    • Individual Grants
    • Alliance Grants
    • Research Success
    • Other Funding
  • Grant Applications
  • About
    • About Us
    • Mission & Objectives
    • Board of Directors
    • Scientific Advisory Board
  • Donate
  • Contact Us

Scientific Advisory Board

The Scientific Advisory Board (SAB) of the Foundation reads as a Who’s Who of CLL research. The SAB ensures that the clinical and scientific aspects of the research are of the highest order of integrity and originality. They provide oversight to ensure the research is conducted with the highest ethical standard. The Scientific Advisory Board oversees the development and implementation of the submission, evaluation, and funding processes for clinical research proposals.

William Plunkett, Ph.D. (chair)
University of Texas MD Anderson Cancer Center

Federico Caligaris-Cappio, M.D.
Instituto Scientifico San Raffaele
Milan, Italy

Daniel Catovsky, M.D., DSc Emeritus Professor
Section of Hemato-Oncology
Institute of Cancer Research, UK

Carlo Croce, M.D.
The Ohio State University Comprehensive Cancer Center
The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Neil Kay, M.D.
Mayo Clinic

Raymond Meyn, Ph.D.
University of Texas MD Anderson Cancer Center

Susan O’Brien, M.D.
University of Texas MD Anderson Cancer Center

Kanti Rai, M.D.
Long Island Jewish Medical Center

Steven Rosen, M.D.
Robert H. Lurie Comprehensive Cancer Center
Northwestern University (Chicago)

William Wierda, M.D., Ph.D.
University of Texas MD Anderson Cancer Center

Donate to CLL
Join Our Mailing List

CLL: Where We Have Been and Looking to the Future

Renowned CLL experts Dr. Michael Keating and Dr. William Wierda talk with Patient Power Founder Andrew Schorr about the evolution of CLL care and the ways CLL Global Research Foundation is investing in the future.

Watch the interview


CLL GLOBAL RESEARCH FOUNDATION

P.O. Box 301402
Houston, TX 77230

MISSION STATEMENT

Our mission is to abolish chronic lymphocytic leukemia (CLL) as a threat to the life and health of patients by accelerating CLL research.

NEWSLETTER

Join Our Mailing List

Join Us on facebook

f_logo small

Copyright © 2021 CLL Global · Website designed by White Space Web Studio · Log in